Summary
Apoptosis is a physiological process that occurs in cells during development and normal cellular processes. The useless, unwanted, or damaged cells die during the apoptotic process. However, if signals instructing cells to carry out apoptosis are lost, a variety of malignant disorders may result. Normal mammary gland development is controlled by a balance between cell proliferation and apoptosis, and the balance is important for normal mammary gland differentiation. The formation of breast cancer will happen as soon as the balance is upset by carcinogens. The uncontrolled cell proliferation and the reduced levels of apoptosis will result in cancer growth. It is useful to detect apoptosis in breast cancer to determine the malignancy of the cancer. It is also important to measure the apoptosis index in breast cancer or other cancers treated with anticancer agents to verify the effect of the anticancer agent. In this chapter, we provide detailed protocols of commonly used apoptosis assays, including DNA ladder formation, enzyme-linked immunosorbent assay for histone/DNA fragment, poly-ADP-ribose-polymerase cleavage assay, and terminal deoxynucleotidyl transferase-mediated dUTP nick-end-labeling assay.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gulbins, E., Jekle, A., Ferlinz, K., Grassme, H., and Lang, F. (2000) Physiology of apoptosis. Am. J. Physiol Renal Physiol. 279, 605–615.
Zhou, Z., Sun, X., and Kang, Y. J. (2001) Ethanol-induced apoptosis in mouse liver: Fas-and cytochrome c-mediated caspase-3 activation pathway. Am. J. Pathol. 159, 329–338.
Suzuki, A., Tsutomi, Y., Akahane, K., Araki, T., and Miura, M. (1998) Resistance to Fas-mediated apoptosis: activation of caspase 3 is regulated by cell cycle regulator p21WAF1 and IAP gene family ILP. Oncogene 17, 931–939.
Chlichlia, K., Peter, M. E., Rocha, M., et al. (1998) Caspase activation is required for nitric oxide-mediated, CD95(APO-1/Fas)-dependent and independent apoptosis in human neoplastic lymphoid cells. Blood 91, 4311–4320.
Zheng, T. S., Schlosser, S. F., Dao, T., et al. (1998) Caspase-3 controls both cytoplasmic and nuclear events associated with Fas-mediated apoptosis in vivo. Proc. Natl. Acad. Sci. USA 95, 13,618–13,623.
Guo, Y., Srinivasula, S. M., Druilhe, A., Fernandes-Alnemri, T., and Alnemri, E. S. (2002) Caspase-2 induces apoptosis by releasing proapoptotic proteins from mitochondria. J. Biol. Chem. 277, 13,430–13,437.
Paroni, G., Henderson, C., Schneider, C., and Brancolini, C. (2002) Caspase-2 can trigger cytochrome C release and apoptosis from the nucleus. J. Biol. Chem. 277, 15,147–15,161.
Boulares, A. H., Yakovlev, A. G., Ivanova, et al. (1999) Role of poly(ADP-ribose) polymerase (PARP) cleavage in apoptosis. Caspase 3-resistant PARP mutant increases rates of apoptosis in transfected cells. J. Biol. Chem. 274, 22,932–22,940.
Simbulan-Rosenthal, C. M., Rosenthal, D. S., Iyer, S., Boulares, H., and Smulson, M. E. (1999) Involvement of PARP and poly(ADP-ribosyl)ation in the early stages of apoptosis and DNA replication. Mol. Cell Biochem. 193, 137–148.
Crompton, M. (2000) Bax, Bid and the permeabilization of the mitochondrial outer membrane in apoptosis. Curr. Opin. Cell Biol. 12, 414–419.
Schuler, M. and Green, D. R. (2001) Mechanisms of p53-dependent apoptosis. Biochem. Soc. Trans. 29, 684–688.
Bruckheimer, E. M., Cho, S. H., Sarkiss, M., Herrmann, J., and McDonnell, T. J. (1998) The Bcl-2 gene family and apoptosis. Adv. Biochem. Eng. Biotechnol. 62, 75–105.
Boulares, A. H., Zoltoski, A. J., Contreras, F. J., Yakovlev, A. G., Yoshihara, K., and Smulson, M. E. (2002) Regulation of DNAS1L3 endonuclease activity by poly(ADP-ribosyl)ation during etoposide-induced apoptosis. Role of poly(ADPribose) polymerase-1 cleavage in endonuclease activation. J. Biol. Chem. 277, 372–378.
Yakovlev, A. G., Wang, G., Stoica, B. A., et al. (2000) A role of the Ca2+/Mg2+-dependent endonuclease in apoptosis and its inhibition by poly(ADP-ribose) polymerase. J. Biol. Chem. 275, 21,302–21,308.
Walker, P. R. and Sikorska, M. (1997) New aspects of the mechanism of DNA fragmentation in apoptosis. Biochem. Cell Biol. 75, 287–299.
Brenner, C., Marzo, I., and Kroemer, G. (1998) A revolution in apoptosis: from a nucleocentric to a mitochondriocentric perspective. Exp. Gerontol. 33, 543–553.
Strange, R., Metcalfe, T., Thackray, L., Dang, M. (2001) Apoptosis in normal and neoplastic mammary gland development. Microsc. Res. Tech. 52, 171–181.
Kumar, R., Vadlamudi, R. K., and Adam, L. (2000) Apoptosis in mammary gland and cancer. Endocr. Relat. Cancer 7, 257–269.
Parton, M., Dowsett, M., and Smith, I. (2001) Studies of apoptosis in breast cancer. BMJ 322, 1528–1532.
Bucci, B., Carico, E., Rinaldi, A., et al. (2001) Biological indicators of aggressiveness in T1 ductal invasive breast cancer. Anticancer Res. 21, 2949–2955.
Lipponen, P. (1999) Apoptosis in breast cancer: relationship with other pathological parameters. Endocr. Relat. Cancer 6, 13–16.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Humana Press Inc.
About this protocol
Cite this protocol
Sarkar, F.H., Li, Y. (2006). Markers of Apoptosis. In: Brooks, S.A., Harris, A. (eds) Breast Cancer Research Protocols. Methods in Molecular Medicine, vol 120. Humana Press, Totowa, NJ. https://doi.org/10.1385/1-59259-969-9:147
Download citation
DOI: https://doi.org/10.1385/1-59259-969-9:147
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-58829-191-2
Online ISBN: 978-1-59259-969-1
eBook Packages: Springer Protocols